Morgan Stanley Sangamo Therapeutics, Inc Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Morgan Stanley holds 745,761 shares of SGMO stock, worth $357,965. This represents 0.0% of its overall portfolio holdings.

Number of Shares

745,761

Previous 1,881,261 60.36%

Holding current value

$357,965

Previous $1.92 Million 74.35%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$0.66 - $1.37 $749,430 - $1.56 Million	-1,135,500 Reduced 60.36%	745,761 $492,000
Q4 2024 Feb 14, 2025	BUY	$0.78 - $2.87 $1.19 Million - $4.39 Million	1,528,514 Added 433.32%	1,881,261 $1.92 Million
Q3 2024 May 14, 2025	SELL	$0.32 - $1.1 $137,168 - $471,515	-428,650 Reduced 54.86%	352,747 $303,000
Q3 2024 Nov 14, 2024	SELL	$0.32 - $1.1 $137,168 - $471,515	-428,650 Reduced 54.86%	352,747 $303,000
Q2 2024 May 14, 2025	SELL	$0.36 - $0.65 $395,951 - $714,911	-1,099,864 Reduced 58.46%	781,397 $281,000
Q2 2024 Oct 17, 2024	BUY	$0.36 - $0.65 $89,037 - $160,761	247,326 Added 46.31%	781,397 $281,000
Q2 2024 Aug 14, 2024	BUY	$0.36 - $0.65 $89,037 - $160,761	247,326 Added 46.31%	781,397 $281,000
Q1 2024 Oct 17, 2024	SELL	$0.42 - $1.38 $103,876 - $341,309	-247,326 Reduced 31.65%	534,071 $357,000
Q1 2024 Aug 16, 2024	SELL	$0.42 - $1.38 $157,472 - $517,410	-374,935 Reduced 41.25%	534,071 $357,000
Q1 2024 May 15, 2024	SELL	$0.42 - $1.38 $157,472 - $517,410	-374,935 Reduced 41.25%	534,071 $357,000
Q4 2023 Aug 16, 2024	BUY	$0.3 - $0.63 $38,282 - $80,393	127,609 Added 16.33%	909,006 $490,000
Q4 2023 Feb 13, 2024	BUY	$0.3 - $0.63 $43,735 - $91,845	145,786 Added 19.1%	909,006 $490,000
Q3 2023 Nov 15, 2023	SELL	$0.58 - $1.47 $8,071 - $20,456	-13,916 Reduced 1.79%	763,220 $457,000
Q2 2023 Aug 14, 2023	SELL	$1.11 - $1.74 $897,763 - $1.41 Million	-808,796 Reduced 51.0%	777,136 $1.01 Million
Q1 2023 May 15, 2023	BUY	$1.66 - $3.67 $871,103 - $1.93 Million	524,761 Added 49.45%	1,585,932 $2.79 Million
Q4 2022 Feb 14, 2023	SELL	$2.77 - $5.07 $91,626 - $167,705	-33,078 Reduced 3.02%	1,061,171 $3.33 Million
Q3 2022 Nov 14, 2022	SELL	$4.27 - $6.39 $1.37 Million - $2.05 Million	-320,276 Reduced 22.64%	1,094,249 $5.36 Million
Q2 2022 Oct 27, 2022	BUY	$3.28 - $6.21 $1.82 Million - $3.45 Million	555,560 Added 64.68%	1,414,525 $5.86 Million
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.21 $1.82 Million - $3.45 Million	555,560 Added 64.68%	1,414,525 $5.86 Million
Q1 2022 Oct 27, 2022	SELL	$5.23 - $7.82 $2.91 Million - $4.34 Million	-555,560 Reduced 39.28%	858,965 $4.99 Million
Q1 2022 May 13, 2022	SELL	$5.23 - $7.82 $2.25 Million - $3.37 Million	-430,619 Reduced 33.39%	858,965 $4.99 Million
Q4 2021 Feb 14, 2022	BUY	$7.29 - $10.97 $2.07 Million - $3.11 Million	283,829 Added 28.22%	1,289,584 $9.67 Million
Q3 2021 Nov 15, 2021	BUY	$9.01 - $12.01 $9.06 Million - $12.1 Million	1,005,755 New	1,005,755 $9.06 Million

Others Institutions Holding SGMO

# of Institutions

139

Shares Held

52.3M

Call Options Held

2.22M

Put Options Held

1.82M

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $75.1M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account